Transactions


DISCLAIMER: Transaction value is approximate and is based on information disclosed by the parties to the transaction or other public sources. In addition, in the case of transactions consummated in currencies other than U.S. dollars, Lazard has converted the value using the exchange rate published on the date of announcement. Lazard makes no representation or warranty with respect to the accuracy or completeness of the value provided

Clear all Clear

Download results

Showing 11 to 20 of 5654 Results

March 20, 2025
United States

QXO to Acquire Beacon Roofing Supply for $11 Billion

$11 Billion

March 19, 2025
Italy, Netherlands

Eni and Vitol to strengthen collaboration in West Africa

$1.6 Billion

March 19, 2025
United States

Paratek Pharmaceuticals to Acquire Optinose, Creating Significant Commercial Expansion Opportunities for XHANCE® in Chronic Rhinosinusitis (CRS)

$330 Million

March 18, 2025
France

Lazard acted as Sole Financial Advisor to Ipsen on its inaugural €500m bond issuance, €1,500m RCF renewal, and inaugural Investment Grade public rating achievement

$2.1 Billion

March 17, 2025
United Kingdom, Portugal

Claranet Group sold its Portuguese subsidiary to NOS SGPS

$159.5 Million

March 14, 2025
Belgium

The Belgian government signs an agreement with ENGIE on the extension of Tihange 3 and Doel 4 nuclear reactors and all obligations related to nuclear waste

$25.1 Billion

March 14, 2025
Italy

Open Fiber has raised additional €1.05 billion credit lines and additional c.€1 billion shareholders’ commitment - on top of the €7.2 billion from the previous project financing facility – to secure its long term funding and complete its c.€10 billion investment plan

$11.5 Billion

March 14, 2025
United Kingdom

IQE plc: Closing of Convertible Loan Note Financing

$22.4 Million

March 13, 2025
Saudi Arabia

Lazard advised BADEA on its successful return to capital markets with a EUR 750m bond issuance

$817.5 Million

March 13, 2025
Ireland, United States

Mallinckrodt and Endo to Combine to Create a Global, Scaled, Diversified Pharmaceuticals Leader

$6.7 Billion